Thursday, July 9, 2026

pharma · Osteopenia · Heat Stress · PTPI

Petros Pharmaceuticals

Petros Pharmaceuticals is a pharma organization headquartered in New York, USA. It trades on NYSE under ticker PTPI. Primary therapeutic focus areas include Osteopenia, Heat Stress, Risk of Heat Stress. NovaPharmaNews li

New York, USA HQ
3 Employees
Public company Type
PTPI · NYSE Ticker
Company details
Status
Public
HQ
New York, USA
Employees
3
Programs
3
Drugs
3
Patents
0
Clinical program

Thermal stress and performance without a pre-cooling protocol

Unknown · mab · Risk of Heat Stress

Thermal stress and performance without a pre-cooling protocol for Risk of Heat Stress is a Unknown program (mab) at Petros Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Internal code 8. Tennis pre-cooling

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Petros Pharmaceuticals
Phase
Unknown
Modality
mab
Indication
Risk of Heat Stress
Status
completed
Trials
1

Clinical trials